中文

Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Geographic evidence hub

Research homeRSS feed

Russia research

Published infectious-disease research classified with a high-confidence geographic relationship to Russia.

Published evidence
3
Diseases
5
Countries
2
Topics
6

Evidence stream

Published literature

03

3 publications

Peer reviewedOpen accessPlagueVaccination
DOI 10.30895/2221-996x-2026-753 ↗

Stability of live plague vaccine production: Analysis of potency using Shewhart charts

I. V. Kasina, I. A. Alekseeva, S. A. Alekseeva +1 more

Biological Products. Prevention, Diagnosis, Treatment

Open article ↗Plague surveillance →
Type
Journal article
Scope
Andorra, Russia

Why it matters nowThe findings indicate that statistical process-control methods were used to evaluate consistency of live plague vaccine potency during production. The supplied evidence does not establish clinical effectiveness, safety outcomes, population protection, or a current public-health threat.

Peer reviewedOpen accessInfluenzaH5N1Genomic epidemiologySurveillance
DOI 10.3390/v17070955 ↗

Detection of a Novel Gull-like Clade of Newcastle Disease Virus and H3N8 Avian Influenza Virus in the Arctic Region of Russia (Taimyr Peninsula).

Derko A, Dubovitskiy N, Prokudin A +10 more

Viruses

Open article ↗Influenza surveillance →
Type
Genomic study
Scope
Russia

Why it matters nowThe manuscript concentrates on avian reservoir dynamics and evolutionary patterns, explicitly noting that direct human health implications remain unaddressed.

Peer reviewedOpen accessCOVID-19SARSVaccinationTreatmentOutbreak investigation
DOI 10.1016/s0140-6736(21)00234-8 ↗

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y Logunov, Inna V Dolzhikova, Dmitry V Shcheblyakov +28 more

The Lancet

Open article ↗COVID-19 surveillance →
Type
Randomised controlled trial
Scope
Russia

Why it matters nowThis interim analysis provides evidence from a large-scale phase 3 trial supporting the efficacy and tolerability of a two-dose adenovirus-vectored COVID-19 vaccine in adults.